EDMONTON, Alberta, Feb. 23, 2024 Ceapro Inc. , today provided an update on its progress across its current business. On December 14, 2023, the Company announced it entered into a definitive.
Ceapro Inc. Announces Dosing of First Patients in Phase globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
– Study being led by Dr. Jean-Claude Tardif at the Montreal Heart Institute – No adverse reactions observed, and study can continue as planned EDMONTON, Alberta, Dec. 13, 2023 Ceapro.